imatinib mesylate

Generic: imatinib

Labeler: mylan institutional inc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name imatinib mesylate
Generic Name imatinib
Labeler mylan institutional inc
Dosage Form TABLET, FILM COATED
Routes
ORAL
Active Ingredients

imatinib mesylate 400 mg/1

Manufacturer
Mylan Institutional Inc

Identifiers & Regulatory

Product NDC 42292-044
Product ID 42292-044_3ed7760b-0703-b47e-e063-6294a90a61f3
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA204644
Listing Expiration 2026-12-31
Marketing Start 2017-09-07

Pharmacologic Class

Classes
bcr-abl tyrosine kinase inhibitors [moa] cytochrome p450 2d6 inhibitors [moa] cytochrome p450 3a4 inhibitors [moa] kinase inhibitor [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42292044
Hyphenated Format 42292-044

Supplemental Identifiers

RxCUI
403878 403879
UNII
8A1O1M485B

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name imatinib mesylate (source: ndc)
Generic Name imatinib (source: ndc)
Application Number ANDA204644 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 400 mg/1
source: ndc
Packaging
  • 30 BLISTER PACK in 1 CARTON (42292-044-03) / 1 TABLET, FILM COATED in 1 BLISTER PACK (42292-044-01)
source: ndc

Packages (1)

Ingredients (1)

imatinib mesylate (400 mg/1)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "3ed7760b-0703-b47e-e063-6294a90a61f3", "openfda": {"unii": ["8A1O1M485B"], "rxcui": ["403878", "403879"], "spl_set_id": ["1debf3a0-7587-47d7-8ea6-e739698d7297"], "manufacturer_name": ["Mylan Institutional Inc"]}, "finished": true, "packaging": [{"sample": false, "description": "30 BLISTER PACK in 1 CARTON (42292-044-03)  / 1 TABLET, FILM COATED in 1 BLISTER PACK (42292-044-01)", "package_ndc": "42292-044-03", "marketing_start_date": "20170907"}], "brand_name": "Imatinib Mesylate", "product_id": "42292-044_3ed7760b-0703-b47e-e063-6294a90a61f3", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Bcr-Abl Tyrosine Kinase Inhibitors [MoA]", "Cytochrome P450 2D6 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Kinase Inhibitor [EPC]"], "product_ndc": "42292-044", "generic_name": "imatinib", "labeler_name": "Mylan Institutional Inc", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Imatinib Mesylate", "active_ingredients": [{"name": "IMATINIB MESYLATE", "strength": "400 mg/1"}], "application_number": "ANDA204644", "marketing_category": "ANDA", "marketing_start_date": "20170907", "listing_expiration_date": "20261231"}